Role of placenta growth factor (PlGF) in human extravillous trophoblast proliferation, migration and invasiveness

Placenta

Volumn 19, Issue 7, 1998, Pages 465-473

  Athanassiades, A ^a   Lala, P K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MATRIGEL; MESSENGER RNA; PROTEOHEPARAN SULFATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST;

EID: 0031689569     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(98)91039-6     Document Type: Article

References (49)

1. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI & Rollason T (1995) Colocalisation of vascular endothelial growth factor & its Flt-1 receptor in human placenta. Growth Factors, 12, 235-243.
2. Ahmed A, Dunk C, Kniss D & Wilkes M (1997) Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest, 76, 779-791.
3. Athanassiades A, Hamilton GS & Lala PK (1998) Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness of human extravillous trophoblast. Biol Reprod, in press.
4. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF & Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol, 143, 1255-1262.
5. Cao Y, Chen H, Zhou L, Chiang M-K, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG & Tsang ML-S (1996) Heterodimers of placenta growth factor/vascular endothelial growth factor: endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem, 271, 3154-3162.
6. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Pelvin R, Ferrara N & Smith SK (1994) Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod, 51, 524-530.
7. Clark DE, Smith SK, Sharkey AM & Charnock-Jones DS (1996) Localization of VEGF and expression of its receptors Fit and KDR in human placenta throughout pregnancy. Hum Reprod, 11, 1090-1098.
8. Clark DE, Smith SK, Licence D & Charnock-Jones DS (1997) Production of a vascular endothelial growth factor antagonist by human trophoblast. Placenta, 18, A.17 (abstract).
9. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ & Neufeld G (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem, 270, 11322-11326.
10. DiSalvo J, Bayne ML, Conn G, Kwok P, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA & Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J Biol Chem, 270, 7717-7723.
11. Folkman J & Shing Y (1992) Angiogenesis. J Biol Chem, 267, 10931-10934.
12. Graham CH & Lala PK (1991) Mechanism of control of trophoblast invasion in situ. J Cell Physiol, 148, 228-234.
13. Graham CH & Lala PK (1992) Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol, 70, 867-874.
14. Graham CH, McCrae KR & Lala PK (1993) Molecular mechanisms controlling trophoblast invasion of the uterus. Troph Res, 7, 237-250.
15. Graham CH, Lysiak JJ, McCrae KR & Lala PK (1992) Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod, 46, 561-572.
16. Graham CH, Connelly IH, MacDougall JR, Kerbel RS, Stetler-Stevenson WG & Lala PK (1994) Resistance of malignant trophoblast cells to both anti-proliferative and anti-invasive effects of transforming growth factor-β. Exp Cell Res, 214, 93-99.
17. Hamilton GS, Lysiak JJ, Watson AJ & Lala PK (1998) Effects of colony stimulating factor (CSF)-1 on human extravillous trophoblast growth and invasion. J Endocrinol, in press.
18. Hauser S & Weich HA (1993) A Heparin-Binding Form of Placenta Growth Factor (P1GF-2) is Expressed in Human Umbilical Vein Endothelial Cells and in the Placenta. Growth Factors, 9, 259-268.
19. Houck KA, Leung DW, Rowland AM, Winer J & Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem, 267, 26031-26037.
20. Irving JA & Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGFβ, IGF II and IGF BP-1. Exp Cell Res, 217, 419-427.
21. Irving JA, Lysiak JJ, Graham CH, Han VKM, Hearn S & Lala PK (1995) Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta, 16, 413-433.
22. Kan M, Wang F, Xu J, Crabb JW, Hou J & McKeehan WL (1993) An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science, 259, 1918-1921.
23. Kaufmann P & Castellucci M (1997) Extravillous trophoblast in the human placenta [Review]. Troph Res, 10, 21-65.
24. Keyt BA, Berleau Nguyen HV, Chen H, Heinsohn H, Vandlen R & Ferrara N (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem, 271, 7788-7795.
25. Khaliq A, Li XF, Shams M, Sisi P, Acevedo CA, Whittle MJ, Weich H & Ahmed A (1996) Localisation of placenta growth factor (PIGF) in human term Placenta. Growth Factors, 13, 243-250.
26. Khoo NKS, Bechberger JF, Shepherd T, Bond SL, McCrae KR, Hamilton GS & Lala PK (1998) SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. 1, Mechanisms responsible for hyperinvasiveness and resistance to antiinvasive actions of TGFβ. Int J Cancer, 77, 429-439.
27. Kurman RJ (1992) The morphology, biology and pathology of intermediate trophoblast: A look back to the present. Hum Pathol, 22, 847-855.
28. Lala PK & Lysiak JJ (1995) Autocrine-paracrine regulation of human placental growth and invasion by locally active growth factors. In Immunology of Human Reproduction (Ed.) Kurpisz, M & Fernandez N, pp. 235-249. Oxford: Bios Scientific Publishers.
29. Lala PK & Hamilton GS (1996) Growth factors, protcases and protease inhibitors in the maternal-fetal dialogue. Placenta, 17, 545-555.
30. Lysiak JJ, Han VKM & Lala PK (1993) Localization of transforming growth factor-α in the human placenta and decidua: role in trophoblast growth. Biol Reprol, 49, 885-894.
31. Lysiak JJ, Johnson GR & Lala PK (1995) Localization of amphiregulin in the human placenta and decidua throughout gestation: role in trophoblast growth. Placenta, 16, 359-366.
32. Lysiak JJ, Connelly IH, Khoo NKS, Stetler-Stevenson W & Lala PK (1994) Role of transforming growth factor-α and epidermal growth factor (EGF) on proliferation and invasion by first trimester human trophoblast. Troph Res, 8, 455-467.
33. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P & Perisco MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA, 88, 9267-9271.
34. Maglione D, Guerriero Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei K, Chou JY & Perisco MG (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene from chromosome 14. Oncogene, 8, 925-931.
35. Park JE, Chen HH, Winer J, Houck KA & Ferrara N (1994) Placenta growth factor-potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Fit-1 but not to Flk-1/KDR. J Biol Chem, 269, 25646-25654.
36. Repesh LA (1989) A new in vitro assay for quantitating tumor cell invasion. Invas Melastas, 19, 192-208.
37. Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning, A Laboratory Manual, 2nd edn. Cold Springs Harbor: Cold Spring Harbor Laboratory Press.
38. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD & Smith SK (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil, 99, 609-615.
39. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H & Sato M (1990) Nucleotide sequence and expression of a novel receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5, 519-524.
40. Shore VH, Wang T-H, Wang C-L, Torry RJ, Caudle MR & Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta, 18, 657-665.
41. 165 to its receptors. Biochem Biophys Res Comm, 203, 1339-1347.
42. 165 via its exon 7-encoded domain. J Biol Chem, 271, 5761-5767.
43. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Sagimura T & Terada M (1994) Markedly increased amounts of messenger RNAs for Vascular Endothelial Growth Factor and Placenta Growth Factor in renal cell carcinoma associated with angiogenesis. Cancer Res, 54, 4233-4237.
44. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL & Shows TB (1991) identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-1683.
45. Terman BI, Khandke L, Dougher-Vermazon M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P & Eisinger M (1994) VEGF receptor subtypes KDR and Flt-1 show different sensitivities to heparin and placenta growth factor. Growth Factors, 11, 187-195.
46. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fasco A & Persico MG (1995) Upregulation of vascular endothelial growth factor (VEGF) and down- regulation of placenta growth factor with malignancy in human thyroid tumors and cell lines. Oncogene, 11, 1569-1579.
47. Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT, Califano D, Monaco C, Mineo A, Santelli G, Manzo G, Botti G, Chiappetta G & Persico MG (1996) Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogens, 13, 577-587.
48. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K & Halmesmaki E (1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod, 56, 489-494.
49. Ziehe M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger HJ, Viglietto G & Persico MG (1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest, 76, 517-531.